Anonymous
Guest
Anonymous
Guest
Boys and girls, it doesn't look good for this stock. $20 Billion market cap is unjustified for one drug, and the market is finally realizing it based on the response lately it seems. SmithBarney doesn't even follow it anymore. I am glad I sold all of mine. The ride was fun, but it is over and most likely never to return. Thanks for helping me make a ton of money, now I plan on making some more on shorts due to future underperformance. The EU can't save this company forever.